Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 4,489 | 4,056 | 4,078 | 3,707 | 4,359 |
| Cost of Goods | 3,677 | 3,825 | 3,344 | 2,976 | 4,235 |
| Gross Profit | 812 | 230 | 734 | 731 | 124 |
| Operating Expenses | 13,919 | 14,555 | 11,573 | 11,020 | 8,530 |
| Operating Income | -12,431 | -13,499 | -10,495 | -9,313 | -8,170 |
| Interest Expense | 106 | 94 | 73 | 99 | 66 |
| Other Income | -186 | -190 | -1,863 | 180 | 58 |
| Pre-tax Income | -12,722 | -13,783 | -12,431 | -9,232 | -8,178 |
| Income Tax | 47 | 47 | 288 | 45 | 448 |
| Net Income Continuous | -12,770 | -13,830 | -12,719 | -9,277 | -8,626 |
| Minority Interests | -165 | -148 | -184 | -206 | -50 |
| Net Income | $-12,605 | $-13,682 | $-12,535 | $-9,071 | $-8,575 |
| EPS Basic Total Ops | -59.97 | -73.46 | -68.97 | -67.47 | -68.97 |
| EPS Basic Continuous Ops | -60.32 | -73.73 | -70.64 | -68.84 | -69.89 |
| EPS Diluted Total Ops | -59.97 | -73.46 | -68.97 | -67.47 | -68.97 |
| EPS Diluted Continuous Ops | -60.32 | -73.73 | -70.64 | -68.84 | -69.89 |
| EBITDA(a) | $-11,887 | $-13,055 | $-10,087 | $-8,948 | $-7,892 |